Related Experiment Video

Updated: Apr 27, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

19.6K

[Cardiovascular diseases and osteoporosis: what is common?]

I L Fedorchenko, D V Nebieridze, A S Safarian

    Terapevticheskii Arkhiv
    |July 17, 2014
    PubMed

    Insights

    Cardiac drugs, particularly nebivolol, may impact osteoporosis progression. Shared mechanisms between atherosclerosis and osteoporosis suggest potential benefits, but more research is needed.

    Area of Science:

    • Cardiovascular pharmacology
    • Bone metabolism
    • Autonomic nervous system

    Context:

    • Atherosclerosis and osteoporosis share common pathophysiological mechanisms.
    • Enhanced sympathetic nervous system activity and endothelial dysfunction are key shared factors.
    • Cardiac drugs, especially beta-adrenoblockers, are being investigated for their potential effects on bone health.

    Purpose:

    • To review the potential influence of cardiac medications on the progression of osteoporosis.
    • To explore the role of nebivolol, a selective beta1-adrenoblocker with vasodilatory properties, in managing osteoporosis.

    Summary:

    • Nebivolol's ability to stimulate nitric oxide synthesis may increase bone mineral density and slow osteoporosis progression.
    • The review highlights shared developmental mechanisms between atherosclerosis and osteoporosis, implicating the sympathetic nervous system and endothelial dysfunction.
    • Current evidence is largely retrospective, necessitating randomized prospective studies for definitive conclusions.

    Impact:

    • Provides a basis for understanding the potential dual role of cardiovascular drugs in managing bone health.
    • Identifies nebivolol as a promising agent for further investigation in osteoporosis treatment.
    • Emphasizes the need for rigorous clinical trials to validate the therapeutic potential of cardiac drugs in osteoporosis prevention and management.

    More Related Videos

    Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat04:30

    Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat

    Published on: February 4, 2021

    3.0K

    Related Concept Videos

    Bone Disorders01:29

    Bone Disorders

    Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
    Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
    7.9K
    Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

    Cardiovascular Drugs: Classification based on Therapeutic Indications

    Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
    4.2K
    Role of Vitamins in Maintaining Bone Health01:25

    Role of Vitamins in Maintaining Bone Health

    The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
    Vitamin A
    Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
    Vitamin B12
    Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
    5.0K
    Essential Minerals for Bone Health01:31

    Essential Minerals for Bone Health

    The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
    Calcium and Phosphorus
    Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
    6.2K
    Psychoneuroimmunology: Cardiovascular Disease01:27

    Psychoneuroimmunology: Cardiovascular Disease

    Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
    A key area of focus in PNI is the relationship between stress and coronary...
    756
    Factors affecting Blood pressure01:28

    Factors affecting Blood pressure

    Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
    Physiological Factors:
    5.1K